Nbt Bank N A Amgen Inc Transaction History

Nbt Bank N A

$1.47 Billion
Q3 2024

A detailed history of Nbt Bank N A transactions in Amgen Inc stock. As of the latest transaction made, Nbt Bank N A holds 5,780 shares of AMGN stock, worth $1.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,780

Previous 6,004 3.73%

Holding current value

$1.7 Million

Previous $1.88 Million 0.69%

% of portfolio

0.13%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $69,301 - $75,573	-224 Reduced 3.73%	5,780 $1.86 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $403,058 - $489,821	1,534 Added 34.32%	6,004 $1.88 Million
Q1 2024 Apr 24, 2024	SELL	$268.87 - $324.56 $43,825 - $52,903	-163 Reduced 3.52%	4,470 $1.27 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $91,029 - $102,691	356 Added 8.32%	4,633 $1.33 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $178,637 - $221,782	817 Added 23.61%	4,277 $1.15 Million
Q2 2023 Jul 24, 2023	SELL	$214.27 - $253.37 $22,498 - $26,603	-105 Reduced 2.95%	3,460 $768,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $9,390 - $11,931	-41 Reduced 1.14%	3,565 $936,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $52,074 - $58,730	-232 Reduced 6.04%	3,606 $813,000
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $100,434 - $114,938	-505 Reduced 11.63%	3,838 $864,000
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $424 - $497	-2 Reduced 0.05%	4,343 $924,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $4,671 - $5,182	20 Added 0.46%	4,345 $1.06 Million
Q1 2021 Apr 08, 2021	BUY	$221.91 - $258.6 $11,095 - $12,930	50 Added 1.17%	4,325 $1.08 Million
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $3,462 - $4,122	-16 Reduced 0.37%	4,275 $983,000
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $12,436 - $13,830	53 Added 1.25%	4,291 $1.09 Million
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $31,649 - $38,838	-160 Reduced 3.64%	4,238 $1 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $728 - $966	-4 Reduced 0.09%	4,398 $892,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $11,731 - $15,078	-62 Reduced 1.39%	4,402 $1.06 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $108,818 - $130,387	625 Added 16.28%	4,464 $864,000
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $5,667 - $6,643	34 Added 0.89%	3,839 $707,000
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $1,808 - $2,038	10 Added 0.26%	3,805 $723,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $33,004 - $38,526	185 Added 5.12%	3,795 $739,000
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $95,424 - $107,578	-515 Reduced 12.48%	3,610 $749,000
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $183,485 - $206,093	-1,105 Reduced 21.13%	4,125 $761,000
Q1 2018 May 22, 2018	SELL	$169.43 - $198.0 $42,357 - $49,500	-250 Reduced 4.56%	5,230 $891,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $98,742 - $110,325	-585 Reduced 9.65%	5,480 $953,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $83,645 - $95,500	500 Added 8.98%	6,065 $1.13 Million
Q2 2017 Aug 08, 2017	BUY	N/A	5,565	5,565 $959,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account